Seroprevalence of Gestational and Neonatal Toxoplasmosis as well as Risk Factors in Yaoundé, Cameroon

Ayeah, Joy Nkain; Oladokun, Adesina; Sumbele, Irene Ule Ngole; Ilesanmi, Abiodun Olatunbosun; Bekindaka, Obase Ngemani

doi:https://doi.org/10.1155/2022/6406259

Journal of Parasitology Research

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Ethical Approval Consent Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 6406259 | https://doi.org/10.1155/2022/6406259

Seroprevalence of Gestational and Neonatal Toxoplasmosis as well as Risk Factors in Yaoundé, Cameroon

Joy Nkain Ayeah,¹Adesina Oladokun,¹Irene Ule Ngole Sumbele,^2,3Abiodun Olatunbosun Ilesanmi,¹and Obase Ngemani Bekindaka¹

Academic Editor: José F. Silveira

Received03 Jul 2021

Revised30 Nov 2021

Accepted06 Dec 2021

Published21 Mar 2022

Abstract

Background. Toxoplasmosis, caused by Toxoplasma gondii in pregnant women, is a significant public health problem due to risk of mother to child transmission. The aim of the study was to determine the seroprevalence of toxoplasmosis in pregnant women and corresponding cord blood among women attending Biyem-Assi and CASS Nkoldongo hospitals in Yaoundé, Cameroon. Methods. An institutional based cross-sectional study was conducted between June 2019 and May 2020 on 300 pregnant women from late second trimester to third trimester. A total of 259 cord blood samples were collected at birth from these women. Toxoplasma gondii-specific IgG and IgM antibodies in maternal and cord blood were detected using the Toxoplasma Enzyme Immunosorbent Assay kit, and potential risk factors captured through questionnaire were identified using binary logistic regression model. Statistical significance was measured at . Results. The overall seroprevalence of gestational and neonatal toxoplasmosis was 80% and 88%, respectively. IgG seropositivity was 72.7%, IgM only was 1.3% and cooccurrence of IgG/IgM was 6% amongst pregnant women. Out of 259 newborn cord bloods, 72.2% were positive for IgG only, 8.9% for IgM only, and 23.9% for both IgG/IgM. Pregnant women 15-24 years (, ) and women with primary level of education (, ) were significantly at risk of infection with Toxoplasma gondii. Conclusion. Gestational and neonatal toxoplasmosis appears to be more common with higher risk of infection in younger women and less educated women. Hence, these findings will serve as baseline data for further investigations on mother to child transmission of toxoplasmosis in Yaoundé and the need for reinforcement of pregnant women toxoplasmosis-related health measures.

1. Introduction

Toxoplasmosis is a zoonotic parasitic disease caused by Toxoplasma gondii (T. gondii). Its definitive hosts are members of the cat family while its intermediate hosts include wide variety of animals and humans [1, 2]. T. gondii circulates in three infectious forms: the tachyzoite, the bradyzoite (able to form tissue cysts), and the sporozoites, formed within the oocysts [1]. T. gondii is ranked fourth among 24 most significant foodborne parasites by the World Health Organisation (WHO) and the United Nations Food and Agriculture Organization (FAO) [3]. Infection occurs through ingestion of oocysts in water or food or soil contaminated with cat faeces, raw or undercooked meat containing tissue cysts, and through transplacental transmission [4, 5]. Toxoplasmosis estimates show that one-third of the world’s population is affected by latent toxoplasmosis and majority of infections are reported in South America and Africa [6]. Infections are most often self-limiting and asymptomatic in immune competent persons; however, infection could result in serious consequences in immune compromised persons [7]. In HIV/AIDS persons, toxoplasmosis is an important opportunistic infection and usually occurs as a result of reactivation of latent infection often manifesting as toxoplasmic encephalitis [8].

Gestational toxoplasmosis is an important public health problem due to the risk of mother to child transmission which may result in devastating consequences such as abortion, stillbirth, premature births, birth defects, congenital toxoplasmosis (CT) and other pregnancy outcomes [9]. More than 80% of pregnant women who acquire T. gondii infection remain asymptomatic; nonetheless, transplacental transmission to foetus remains possible and may be associated with devasting consequences [10]. The risk of mother to child transmission increases with increase in gestational age. For untreated pregnant women the transmission rate varies from 25% in the first trimester to 65% in the third trimester [11]. Among newborns, more than 60% cases of congenital toxoplasmosis are usually asymptomatic [11]. Since congenital transmission of T. gondii occurs mostly in women who acquire infection during gestation, determining whether Toxoplasma infection has occurred during pregnancy is critical [12]. Diagnosis involves detection of specific immunoglobulins (Ig) G and M antibodies by serology whereby IgM is a marker of acute or recent infection while IgG is a marker of past or chronic infection [13]. In addition, confirmatory tests such as the IgG avidity or PCR test is always useful in eliminating false positive IgM because its erroneous interpretation could be misleading [5]. Many studies indicate that gestational toxoplasmosis varies geographically. Existing reports showed a prevalence of 68.4% in Brazil [14], 6.4% in South Africa [15], 42.5% in Malaysia [16], 36.7% in France [17], 92.5% in Ghana [18], 5.87% in Zambia [19], 30.9% in Tanzania [20], and 20.3% in Burkina Faso [21]. In different regions of Cameroon, seroprevalence of over 50% have been reported [22–25], while other regions have had seroprevalence rates of less than 50% [26, 27].

Since majority of infections with T. gondii are asymptomatic, early detection, treatment, and primary prevention remains the best way to limit the risk of congenital infection [10]. A number of risk factors have been found associated with variations in seroprevalence of T. gondii, age, [28, 29] keeping pet cats, contact with soil, parity [30], and eating unwashed raw vegetables [10]. Nonetheless, conflicting results about which factors influence the vulnerability of humans to T. gondii infection have been reported. For instance, a study in Ethiopia [31] could not relate the high prevalence of T. gondii antibodies in pregnant women to any known risk factor. For proper implementation of primary preventive ways for effectiveness, knowledge of possible risk factors in each population needs to be frequently assessed to identify the risk factors specific to that population.

Instituted systematic screening of pregnant women throughout the gestational period in Europe has proven effective in detecting acute infections and congenital toxoplasmosis [11, 32]. Nevertheless, Cameroon does not have an instituted program for systematic screening of T. gondii infections in pregnant women or in newborns. Screening of mother and newborn at birth may be an effective strategy for identifying cases of congenital toxoplasmosis thus enabling immediate treatment and limiting its complications such as chorioretinitis later in life [33]. Despite the documented risk of mother to child transmission of T. gondii in literature, there is no comprehensive and documented survey on newborn cord samples for the case of Cameroon. The objective of the study was to determine the seroprevalence of gestational and neonatal toxoplasmosis as well as associated risk factors.

2. Methods

2.1. Study Design, Site, Population, and Ethical Aspects

This cross-sectional study was conducted in the Central Region of Cameroon, specifically in the city of Yaoundé. Yaoundé is the administrative and political capital of Cameroon, located between latitudes 3°47-3°56 North and longitudes 11°10-11°45 East at an altitude of 750m [34]. Yaoundé, a highly cosmopolitan city, has a population of over 2.6 million inhabitants regrouped from various ethnic groups in Cameroon. Yaoundé has a tropical climate of four seasons: 2 rainy seasons and 2 dry seasons. It has an average annual rainfall of 1643 mm for an average temperature of 23.7°C.

Two representative hospitals were selected from two district health areas: Biyem-Assi District Hospital and Centre d’Animation Sociale et Sanitaire (CASS) de Nkoldongo. These health institutions were selected due to their strategic locations that make them receive patients and pregnant women from all over the city. The study population comprised of pregnant women from 2^nd trimester to their 3^rd trimester or at term, between the ages of 15 and 49 years old living within or around the city of Yaoundé. Cord blood (CB) was collected after childbirth from each corresponding live born at birth. Participants were excluded from the study if they refused to sign the consent form, had incomplete data in the questionnaire, and/or had inadequate samples. This study was approved by the Institutional Review Board of the University College Hospital of Ibadan, Nigeria (Ref#18/0602) and the Cameroon National ethics Committee (No. 2019/11/55/CE/CNERSH/SP).

2.2. Sample Size and Sampling Procedures

Following Cochran’s formula (1963) [35], a total sample size of 342 was calculated from a previous Toxoplasma seroprevalence of 65.5% among pregnant women in Douala, Littoral Region of Cameroon [22]. Sampling of pregnant women was done by convenience, and 360 pregnant women were approached with consent forms to sign after study was explained to them, but 310 fully consented to the study. However, only 300 pregnant women completed questionnaires and gave venous blood samples. This corresponds to a statistical % of the required sample size indicating that results obtained in this study are reasonably true. At delivery, only 259 cord blood samples were collected. Some women had complications and were transferred to referral hospital for delivery, while other deliveries were missed and 4 deliveries were stillbirth.

2.3. Sample Collection and Processing

Approximately 3-5 ml of venous blood from mothers and cord blood from newborn umbilical cord were collected into well-labelled sterile dry tubes each. The samples were placed on ice blocks and transported to the Immunology Laboratory at the Biotechnology Centre of Nkolbisson, Yaoundé. Samples from the mother were collected during pregnancy at late second trimester, third trimester, and even near delivery. Serum was obtained after centrifugation of blood samples was done at 2000 rpm for 10 minutes. The sera were preserved at -20°C until laboratory analysis.

2.4. Questionnaire Administration

Questionnaire was pretested on 10 pregnant women. Responses were evaluated and questions adjusted for clearer understanding. Questionnaires were formulated based on literature and administered in English or French depending on language preference of participants. Information on sociodemographic factors (age, marital status, educational status, profession, and household income), obstetrical status (antenatal (ANC) visits, gravidity, parity, history of abortion, and history of stillbirth), nutritional habits (tasting of meat undercooked meat, consumption of grilled meat, consumption of bushmeat, eating unwashed vegetables/fruits, and drinking water source), farm work, cats at home, cats in neighbourhood, and HIV status was collected.

2.5. Serological Method

The enzyme-linked immunosorbent assay to detect specific IgG and IgM against toxoplasmosis was carried out using commercial anti Toxoplasma immunoassay kits, Rapid Labs limited (Toxo EIA Rapid Labs kit, UK, Ltd.). The analysis was conducted following the manufacturer’s instruction with a little modification. Results were read using the ELISA microplate reader, and index values less than 1.1 and greater than 1.1 were considered negative and positive, respectively, for both antibodies. The same serological kit (same manufacturer) was used for both mother and cord blood samples in order to preserve the internal validity of this study.

2.6. Statistical Analysis

Data was subjected to statistical analysis in IBM-SPSS™ (Statistical Package for the Social Sciences version 21, SPSS Inc., Chicago, IL, USA). Descriptive statistics were presented as frequencies, means, and percentages. Chi-square () was used to measure associations between Toxoplasma infection (positive and negative) and characteristics of pregnant women through cross tabulations. Data from women with known IgG and IgM serostatus were included in the analysis. Binary logistic regression analysis for Toxoplasma infection (positive or negative) was performed to examine the level of associations. Only variables that had a threshold of were introduced into the binary logistic model. Binary logistic regression was conducted for specific IgG serostatus only since IgM anti-T. gondii-positive women were few. Crude odd ratios (COR) and adjusted odd ratios (AOR) were obtained. value < 0.05 was considered statistically significant.

3. Results

3.1. Description of Study Characteristics of Pregnant Women

Pregnant women included in the study ranged between the ages of 16 and 41 with a mean age of years. Most of the women (55.3%, 166/300) in the study were aged 24 to 34 years. Majority of women (72%) had a secondary education and 62% of women had an income between 50,000 and 100,000FCFA (Table 1). With respect to profession, students, self-employed, and unemployed persons had similar proportions (24.7%, 26.7%, and 27%, respectively). A little fraction of the population, 27(9%) were HIV positive. Majority of the participants (52.3%, 157) already had multiple pregnancies and had 2-4 children (53.7%). Only 15 (5%) had a history of stillbirth while 97 (32.3%) had a history of spontaneous abortion. Most of the women consumed bush meat (58.7%, 176) and grilled meat locally called “soya” (88%, 264). A minority of pregnant women (9.7%, 29) reported that they drank water from untreated water or mixed water sources where treated water (tap water, spring water, and mineral water) and untreated/mixed sources (streams alone or streams and treated water). Only 19.7% of subjects were involved in farm work and 22% of the pregnant women had cats at home while 33.2% had cats and/or other animals in the neighbourhood as shown in Table 1. On the other hand, a total of 259 cord blood samples were collected from live births.

3.2. Seroprevalence of T. gondii in Pregnant Women and Corresponding Newborns

Of the 300 women tested for specific IgG and IgM antibodies against gestational toxoplasmosis, a total of 242 (80%) were positive. Seropositivity for Toxoplasma IgG only was highest (72.7%, 218) classified as latent or chronic infection. Seropositivity for Toxoplasma IgM only was 1.3% (4), and the cooccurrence of IgG/IgM only was 6% (18) classified as acute infections. Thus, the total occurrence of specific IgMs were 7.3%. While those who tested negative for both Toxoplasma antibodies (IgG, IgM) were classified as susceptible. The age-specific seropositivity alongside other sociodemographic and clinical factors is displayed in Table 2. There was an incremental seroprevalence with age that approached significance (). The seroprevalence of specific antibody IgG and IgM in association with other factors were not statistically significant as shown in Table 2.

Among the 259 umbilical cord blood samples tested for specific IgG and IgM antibodies against neonatal toxoplasmosis, a total seroprevalence of 88% (228) was obtained. Cord blood (55.2%, 143) was seropositive for specific IgG only, 8.9% [23] seropositive for IgM only, and 23.9% (62) seropositive for both IgG/IgM. An intriguing observation of 41.5% (34/82) newborn CB positive for IgM but born from totally negative mothers was noted.

3.3. Risk Factors Associated with T. gondii among Pregnant Women

Following a selection criterion () of independent variables in the univariate analysis for entry into the binary logistic regression model, only age, educational status, household income, parity, history of stillbirth, presence of cats at home, and presence of cats in neighbourhoods were included in the model. As shown in Table 3, age and educational status were identified as significant risk factors of infection. Pregnant women 15-24 years old had 4.6-fold odds of being infected with T. gondii (, ). On the other hand, women with primary educational level were 3.9 times more likely to be infected with T. gondii (, ) when compared with their counterparts. While women who had a history of stillbirth were significantly protected against T. gondii IgG seropositivity (, ), other factors like household income, parity, presence of cats at home, or cats/animals in the neighbourhood were not significantly associated with T. gondii IgG seroprevalence (Table 3).

4. Discussion

Gestational toxoplasmosis is endemic and a disease of public health significance in Cameroon. Unlike many studies, this study concurrently determined the seroprevalence of toxoplasmosis in pregnant women and newborn cord blood. The study showed that the seroprevalence of toxoplasmosis in pregnancy was 80%. This is similar to 80.3% obtained in the Democratic Republic of Congo (DRC) amongst pregnant women [36]. However, this was lower than 85.5% reported in Ethiopia [37] and 92.5% in Ghana [18]. In Cameroon, the seroprevalence was similar to a recent (78.6%) study in Douala [22] and an earlier study in Yaoundé (77.1%). [25] On the other hand, the seroprevalence obtained in this study is substantially higher than most studies within Cameroon: 54.5% in Njinikom, North West Region, [24] 70% in Yaoundé [23], 32.5% in Buea [27], and 45.5% in Mbouo-Bandjoun, West Region [26]. Such variations in the seroprevalence of toxoplasmosis may be due to differences in geographical locations, characteristics of the pregnant women such as age, educational level, handling of cats, hygiene, and feeding-related practices of toxoplasmosis. [38] The use of different serological methods and the difference in sensitivity may also be responsible for the divergences. [39]

Majority (72.7%) of pregnant women were reactive for Toxoplasma IgG antibody only, indicating that most infections were past or latent infections. This is a common trend across most studies where majority of infections are often past infections with few or no cases of Toxoplasma-specific IgM, the marker of recent infection. Its presence in the absence of IgG evokes a recent infection and needs confirmatory test. [40] In this study, those that were exclusively positive for specific Toxoplasma IgM in pregnant women (1.3%) was similar to that reported in the local studies [23, 24] in Cameroon. During a Toxoplasma infection, IgM antibodies tend to appear earlier and so are the first class of antibodies detected after a primary infection. However, they also decline very rapidly than IgG antibodies and this is probably why most Toxoplasma infections detected are IgG [12]. This could also be an indication of low active transmission of toxoplasmosis. The high seroprevalence of anti-T. gondii IgG may indicate that most women got infected possibly 6 to 12 months before pregnancy, as reported by previous authors [41]. Dating of infection is done with the IgG avidity test, which unfortunately, was a limitation in this study. Generally, women who get infected with toxoplasmosis before pregnancy usually do not transmit the infection to their foetuses because it is believed they have gained immunity. But when infection occurs during pregnancy, the risk of transmission is important. On the other hand, the presence of anti-T. gondii IgM and cooccurrence of anti-T. gondii IgM and IgG are a cause for concern and presents a risk for foetal infection. Hence, follow-up test including IgG avidity test are further recommended [42].

Age was found to be positively associated with seropositivity of specific Toxoplasma IgG in this study. This is similar to findings in Tanzania [20] and in Nigeria [43]. Younger women, 15-24 years, were more likely infected than their older counter parts, and this is contrary to results obtained in North West Ethiopia [44]. However, in line with a study in Zambia pregnant women 15-24 years old had the highest odds of being infected with T. gondii compared to their older counterparts [19]. Other studies in Ethiopia did not find any significant association between age and seroprevalence of T. gondii [31].. Educational status of the women was significantly associated to T. gondii seroprevalence. Findings from the study revealed that all pregnant women who had no formal level of education were all seropositive for Toxoplasma IgG. Furthermore, women with primary level of education were 3.9 times more likely to be infected with T. gondii compared to those with secondary level of education. This probably indicates that low level of education is a risk factor for toxoplasmosis among pregnant women. A similar outcome was observed in a study by Nguefack and colleagues where the lower the educational level of subjects was, the higher was the seroprevalence of T. gondii [22]. Contrary to this, a study in Burkina Faso showed that higher level of education (at least secondary level) was significantly associated with higher odds of being infected compared to those with no formal or primary level of education [45].

Observations from the study revealed that women who had a history of stillbirth had a significantly reduced risk of being seropositive for Toxoplasma IgG. This is quite unexpected and contrary to most findings; Li and colleagues in a meta-analysis reported that women with history of stillbirth were more infected with T. gondii infection than normal women [9]; Singh and collaborators in India showed that stillbirths were more common in T. gondii-infected women than negative ones [46]. On the other hand, no significant associations were found between marital, professional, and HIV statuses, history of abortion, gravidity and parity, water source, eating grilled meat, tasting undercooked meat, presence of cats at home or in the neighbourhood, and Toxoplasma antibody seropositivity in the current study. However, some factors were found to be statistically significant in other similar studies: presence of cats at home and history of abortion in Ethiopia [47], HIV status in West Cameroon [26], and source of drinking water in Douala, Cameroon [23].

This is probably the first study that explored neonatal toxoplasmosis from cord blood in Cameroon. Although screening of pregnant women for toxoplasmosis is recommended in hospital settings in Cameroon, it is not obligatory nor a free of cost prenatal screening programme like in some European countries such as France and Austria [48]. Since many newborns do not exhibit clinical signs at birth, performing test only in those with clinical symptoms will likely fail to identify majority of infected infants at birth [1]. Thus, screening of newborn at birth can help to detect infections that were missed during pregnancy thereby detecting any case of congenital infection.

The total toxoplasmosis seroprevalence of 88% obtained from CB in this study was higher than 39.5% obtained in a similar study conducted in Ghana by Kwofie and colleagues [49]. In the present study, the CB seropositivity of IgG only of 55.2% was higher than 39.5% and 19.6% obtained in Ghana [49] and Iran [50], respectively. The presence of specific IgG in CB reflects the presence of specific IgG in maternal serum implying that the mother has been chronically infected or exposed in the past or underwent seroconversion during pregnancy. The seropositivity of IgM anti-T. gondii-specific antibody, 7.3% among pregnant women in the present study was quite higher in relation to only one borderline IgM anti-T. gondii obtained by Nahvi and colleagues [50]. Unlike IgG, IgM antibodies are not transferable via the placental barrier, as such the detection of anti-T. gondii IgM in CB indicates foetal production of specific IgM and therefore a high likelihood of foetal infection [51]. However, the use of molecular test for confirmation will be reassuring. Furthermore, a strange but intriguing result was observed in this study where 13.1% newborn CB seropositive for IgM were obtained from IgG-negative and IgM-negative pregnant women. Such a scenario may either indicate a false positive result [52] or a case of high mother to child transmission at the end of pregnancy, usually >70% rate. A similar scenario was reported by Sensini in 2006, where a severe case of neonatal toxoplasmosis was demonstrated by positive IgM, IgG, and PCR in a neonate born from a mother seronegative for both IgG and IgM T. gondii antibodies in repeated serum samples [42]. Worthy of note, majority of samples in this study were collected at the third trimester near birth.

4.1. Limitations

Even though the study had as limitation the nonconfirmation of the specific Toxoplasma IgM in pregnant women and cord blood by confirmatory tests (IgG avidity and/or PCR test), this finding remains invaluable in signalling the occurrence of infection in pregnant women and their newborn. Secondly, the fact that the assessment of potential toxoplasma risk factors was done retrospectively, it is likely that some element of recall bias may have been introduced.

5. Conclusions

Gestational and neonatal toxoplasmosis appears to be more common than earlier reported and the risk of infection higher in younger pregnant women. This highlights extend of the burden of latent T. gondii infection in pregnant women and provides knowledge for public health personnel to plan appropriate intervention to mitigate mother to child transmission of toxoplasmosis in Cameroon. However, a countrywide determination of the prevalence of T. gondii infection in both pregnant women and newborns is invaluable to assert some of the observations. Furthermore, the implementation of obligatory routine low-cost screening algorithm in addition to sensitization of women against various risk factors of toxoplasmosis should be considered an effective way to track and follow up women at risk of transmitting infection to their newborns.

Data Availability

The data sets analysed during the current study are available from the corresponding author on reasonable request.

Ethical Approval

The study was approved by the Cameroon National ethics Committee (N^o 2019/11/55/CE/CNERSH/SP) and the Institutional Review Board of the University College Teaching Hospital of Ibadan, Nigeria (Ref#18/0602). Administrative authorization and permissions were also obtained from the various health institutions in Cameroon. Participants were approached in either English or French languages depending on their preference, and the study was explained to them.

An informed consent was obtained from participants. Confidentiality of patient information was respected.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors’ Contributions

Joy Nkain Ayeah contributed to the conceptualization, data curation, laboratory analysis, investigation, and statistical analysis. Irene U.N. Sumbele contributed to the supervision, investigation, writing, editing, review, and validation. Adesina Oladokun contributed to the supervision, writing, editing, and validation. Abiodun O. Ilesanmi contributed to the supervision, editing, and validation. Bekindaka Ngemani Obase contributed to the data curation and laboratory analysis.

Acknowledgments

We are thankful to the Pan African University of Life and Earth Sciences Institute Including Agriculture (PAULESI) for supporting us with research allowances. Sincere gratitude is given to Professor Rose Gana Fomban Leke for hosting my work in her laboratory, the Immunology Laboratory at the Biotechnology Cntere, Nkolbisson. Gratitude to the entire staff and students of the Immunology Laboratory at the Biotechnology Centre of Nkolbisson, University of Yaoundé I. We appreciate the director and staff of CASS, Biyem-Assi District Hospital, and the study participants for their great collaboration towards this work.

References

P. A. Moncada and J. G. Montoya, “Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment,” Diagnosis and Treatment, vol. 10, no. 7, pp. 815–828, 2012.
View at: Publisher Site | Google Scholar
A. M. Tenter, A. R. Heckeroth, and L. M. Weiss, “Toxoplasma gondii: from animals to humans,” International Journal for Parasitology, vol. 30, no. 12-13, pp. 1217–1258, 2000.
View at: Publisher Site | Google Scholar
Food and Agriculture Organization of the United Nations and World Health Organization, “Multicriteria-Based Ranking for Risk Management of Food-Borne Parasites,” Microbiological Risk Assessment Series (MRA), vol. 23, 2014, http://www.fao.org/publications/card/en/c/ee07c6ae-b86c-4d5f-915c-94c93ded7d9e/.
View at: Google Scholar
D. Hill and J. P. Dubey, “Toxoplasma gondii: transmission, diagnosis and prevention,” Clinical Microbiology and Infection, vol. 8, no. 10, pp. 634–640, 2002.
View at: Publisher Site | Google Scholar
J. G. Montoya and F. Rosso, “Diagnosis and management of toxoplasmosis,” Clinics in Perinatology, vol. 32, no. 3, pp. 705–726, 2005.
View at: Publisher Site | Google Scholar
S. K. Halonen and L. M. Weiss, “Toxoplasmosis,” Neuroparasitology and Tropical Neurology Vol 114, Elsevier, 2013.
View at: Publisher Site | Google Scholar
J. G. Montoya and O. Liesenfeld, “Toxoplasmosis,” The Lancet, vol. 363, no. 9425, pp. 1965–1976, 2004.
View at: Publisher Site | Google Scholar
V. Nissapatorn, “Review toxoplasmosis in HIV/AIDS : a living legacy,” Southeast Asian Journal Of Tropical Medicine And Public Health, vol. 40, no. 6, p. 1158, 2009.
View at: Google Scholar
X.-L. Li, H.-X. Wei, H. Zhang, H.-J. Peng, and D. S. Lindsay, “A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection,” PLoS One, vol. 9, no. 5, article e97775, 2014.
View at: Publisher Site | Google Scholar
J. D. Kravetz and D. G. Federman, “Toxoplasmosis in pregnancy,” The American Journal of Medicine, vol. 118, no. 3, pp. 212–216, 2005.
View at: Publisher Site | Google Scholar
J. B. McAuley, “Congenital toxoplasmosis,” Journal of the Pediatric Infectious Diseases Society, vol. 3, Supplement 1, pp. S30–S35, 2014.
View at: Publisher Site | Google Scholar
J. G. Montoya, “Laboratory diagnosis of Toxoplasma gondii infection,” International Journal of Medical Sciences, vol. 6, no. 3, pp. 135-136, 2009.
View at: Publisher Site | Google Scholar
J. G. Montoya and J. S. Remington, “Clinical Practice: Management ofToxoplasma gondiiInfection during Pregnancy,” Clinical Infectious Diseases, vol. 47, no. 4, pp. 554–566, 2008.
View at: Publisher Site | Google Scholar
M. G. Da Silva, M. C. Vinaud, and A. M. De Castro, “Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014,” PLoS One, vol. 10, no. 11, pp. 1–15, 2015.
View at: Publisher Site | Google Scholar
K. Kistiah, J. Winiecka-Krusnell, A. Barragan, A. Karstaedt, and J. Frean, “Seroprevalence of Toxoplasma gondii infection in HIV-positive and HIV-negative subjects in Gauteng, South Africa,” Southern African Journal of Epidemiology and Infection, vol. 2015, no. 4, pp. 225–228, 2017.
View at: Publisher Site | Google Scholar
H. Andiappan, V. Nissapatorn, N. Sawangjaroen et al., “Comparative study on Toxoplasma infection between Malaysian and Myanmar pregnant women,” Parasites & Vectors, vol. 7, no. 1, 2014.
View at: Publisher Site | Google Scholar
M. Tourdjman, C. Tcheandjieu, H. De Valk, V. Goulet, and Y. Le Strat, “Toxoplasmosis among pregnant women in France: trends in seroprevalence and associated factors between 1995 and 2010,” Depistages au cours la grossesse a la Naiss donnees Epidemiol Recent, vol. 15, no. 16, pp. 264–272, 2015, http://www.invs.sante.fr/beh/2015/15-16/pdf/2015_15-16.pdf.
View at: Google Scholar
I. Ayi, S. A. A. Edu, D. Boamah, K. M. Bosompem, and D. Edoh, “Sero-epidemiology of toxoplasmosis amongst pregnant women in the Greater Accra Region of Ghana,” Ghana Medical Journal, vol. 43, no. 3, pp. 107–114, 2010.
View at: Google Scholar
C. Frimpong, M. Makasa, L. Sitali, and C. Michelo, “Seroprevalence and determinants of toxoplasmosis in pregnant women attending antenatal clinic at the university teaching hospital, Lusaka, Zambia,” BMC Infectious Diseases, vol. 17, no. 1, pp. 1–8, 2017.
View at: Publisher Site | Google Scholar
B. Mwambe, S. E. Mshana, B. R. Kidenya et al., “Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania,” Parasites and Vectors, vol. 6, no. 1, pp. 2–6, 2013.
View at: Publisher Site | Google Scholar
L. S. G. Linguissi, B. M. Nagalo, C. Bisseye et al., “Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 10, pp. 810–813, 2012.
View at: Publisher Site | Google Scholar
C. T. Nguefack, I. K. Meumeu, and G. P. Ngaba, “Prevalence and Factors Associated with Toxoplasma Gondii Immunization among Pregnant Women in Douala â Cameroonâ,” Journal of Womens Health, Issues and Care, vol. 5, no. 6, 2016.
View at: Publisher Site | Google Scholar
A. L. Njunda, J. C. N. Assob, D. S. Nsagha, H. L. Kamga, P. F. Nde, and V. C. Yugah, “Seroprevalence of Toxoplasma gondii infection among pregnant women in Cameroon,” Journal of Public Health in Africa, vol. 2, no. 2, pp. 98–101, 2011.
View at: Publisher Site | Google Scholar
E. C. Wam, L. F. Sama, I. M. Ali, W. A. Ebile, L. A. Aghangu, and C. B. Tume, “Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon,” BMC Research Notes, vol. 9, no. 1, p. 406, 2016.
View at: Publisher Site | Google Scholar
P. M. Ndumbe, A. Andela, J. Nkemnkeng-Asong, E. Watonsi, and P. Nyambi, “Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon,” Medical Microbiology and Immunology, vol. 181, no. 3, pp. 127–130, 1992.
View at: Publisher Site | Google Scholar
F. Guemgne Todjom, E. Makou Tsapi, G. A. Gamago, P. Vignoles, J. Wabo Pone, and F. F. Djuikwo Teukeng, “Seroprevalence of toxoplasmosis and associated risk factors in pregnant women at the Protestant Hospital, Mbouo-Bandjoun, Cameroon,” African Journal of Clinical and Experimental Microbiology, vol. 20, no. 3, p. 221, 2019.
View at: Publisher Site | Google Scholar
J. L. Ndamukong-nyanga, N. Jacqueline, D. Flavia, N. C. Ndamukong, and D. N. Nji, “Socio-Demographic Factors and Attitudes Influencing the Seroprevalence of Toxoplasmosis among Pregnant Women in Buea, Sw Cameroon,” South Asian Journal of Parasitology, vol. 3, no. 4, pp. 1–11, 2020.
View at: Google Scholar
N. Bartelheimer, A. Winter, A. J. N. Queiroz et al., “Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, northeastern Brazil,” The American Journal of Tropical Medicine and Hygiene, vol. 83, no. 3, pp. 528–533, 2010.
View at: Publisher Site | Google Scholar
K. M. Boyer, E. Holfels, N. Roizen et al., “Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening,” American Journal of Obstetrics and Gynecology, vol. 192, no. 2, pp. 564–571, 2005.
View at: Publisher Site | Google Scholar
V. Nissapatorn, M. A. Noor Azmi, S. M. Cho et al., “Toxoplasmosis: prevalence and risk factors,” Journal of Obstetrics and Gynaecology, vol. 23, no. 6, pp. 618–624, 2003.
View at: Publisher Site | Google Scholar
W. Gelaye, T. Kebede, and A. Hailu, “High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two Hospitals of Addis Ababa, Ethiopia,” International Journal of Infectious Diseases, vol. 34, pp. 41–45, 2015.
View at: Publisher Site | Google Scholar
M. M. Hampton, “Congenital toxoplasmosis: a review,” Neonatal Network, vol. 34, no. 5, pp. 274–278, 2015.
View at: Publisher Site | Google Scholar
Ostrea EM Jr, D. M. Bielawski, and Posecion NC Jr, “Meconium analysis to detect fetal exposure to neurotoxicants,” Archives of Disease in Childhood, vol. 91, no. 8, pp. 628-629, 2006.
View at: Publisher Site | Google Scholar
M. Tchindjang, P. Atangana, A. Bopda, and B. E. Messi, “Administrative and spatial evolution of Yaounde town from administrative and spatial evolution of yaounde town from 1898 to 1992,” 1992.
View at: Google Scholar
L. K. Kish, “L survey sampling,” Science 1995, Wiley inter, p. 3014, 1963.
View at: Google Scholar
Y. Doudou, P. Renaud, L. Coralie et al., “Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo,” Asian Pacific Journal of Tropical Biomedicine, vol. 4, no. 1, pp. 69–74, 2014.
View at: Publisher Site | Google Scholar
F. Abamecha and H. Awel, “Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia,” BMC Infectious Diseases, vol. 16, no. 1, 2016.
View at: Publisher Site | Google Scholar
J. L. Jones, V. Dargelas, J. Roberts, C. Press, and J. S. Remington, “Risk factors for Toxoplasma gondii infection in the United States,” Clinical Infectious Diseases, vol. 49, no. 6, pp. 878–884, 2009.
View at: Google Scholar
O. Villard, B. Cimon, C. L’Ollivier et al., “Help in the choice of automated or semiautomated immunoassays for serological diagnosis of toxoplasmosis: evaluation of nine immunoassays by the French National Reference Center for Toxoplasmosis,” Journal of Clinical Microbiology, vol. 54, no. 12, pp. 3034–3042, 2016.
View at: Publisher Site | Google Scholar
O. Villard, B. Cimon, C. L'Ollivier et al., “Serological diagnosis of Toxoplasma gondii infection : recommendations from the French National Reference Center for Toxoplasmosis,” Toxoplasmosis, vol. 84, no. 1, pp. 22–33, 2016.
View at: Publisher Site | Google Scholar
A. Many and G. Koren, “Motherisk update: toxoplasmosis during pregnancy,” Canadian Family Physician, vol. 52, no. JAN., pp. 29–32, 2006.
View at: Google Scholar
A. Sensini, “Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis,” Clinical Microbiology and Infection, vol. 12, no. 6, pp. 504–512, 2006.
View at: Publisher Site | Google Scholar
O. T. Adeniyi, S. S. Adekola, and O. M. Oladipo, “Seroepidemiology of toxoplasmosis among pregnant women in Osogbo, Southwestern, Nigeria,” Journal of Infectious Diseases and Immunity, vol. 10, no. 2, pp. 8–16, 2018.
View at: Publisher Site | Google Scholar
B. Agmas, R. Tesfaye, and D. N. Koye, “Seroprevalence of toxoplasma gondii infection and associated risk factors among pregnant women in Debre Tabor, Northwest Ethiopia,” BMC Research Notes, vol. 8, no. 1, p. 107, 2015.
View at: Publisher Site | Google Scholar
S. Bamba, M. Cissé, I. Sangaré, A. Zida, S. Ouattara, and R. T. Guiguemdé, “Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso,” BMC Infectious Diseases, vol. 17, no. 1, 2017.
View at: Publisher Site | Google Scholar
M. Singh, R. Ranjan, Y. Pradeep, S. Quereshi, and M. Sahu, “Seroprevalence of toxoplasmosis in pregnant females attending a tertiary care hospital in Uttar Pradesh, India and its effect on perinatal morbidity and mortality,” India and Its Effect on Perinatal Morbidity and Mortality, vol. 3, no. 1, pp. 50–55, 2016.
View at: Publisher Site | Google Scholar
K. Awoke, E. Nibret, and A. Munshea, “Sero-prevalence and associated risk factors of Toxoplasma gondii infection among pregnant women attending antenatal care at Felege Hiwot Referral Hospital, northwest Ethiopia,” Asian Pacific Journal of Tropical Medicine, vol. 8, no. 7, pp. 549–554, 2015.
View at: Publisher Site | Google Scholar
F. Peyron, R. Mc Leod, D. Ajzenberg et al., “Congenital toxoplasmosis in France and the United States: one parasite, two diverging approaches,” PLoS Neglected Tropical Diseases, vol. 11, no. 2, pp. e0005222–e0005229, 2017.
View at: Publisher Site | Google Scholar
K. D. Kwofie, A. Ghansah, J. H. N. Osei et al., “Indication of risk of mother-to-child Toxoplasma gondii transmission in the Greater Accra Region of Ghana,” Maternal and Child Health Journal, vol. 20, no. 12, pp. 2581–2588, 2016.
View at: Publisher Site | Google Scholar
M. Nahvi, S. Shojaee, H. Keshavarz, M. Salimi, and M. Mohebali, “Detection of Toxoplasma gondii in cord blood samples from neonates in Tehran, Iran,” Iranian Journal of Public Health, vol. 48, no. 5, pp. 912–916, 2019.
View at: Publisher Site | Google Scholar
F. Robert-Gangneux and O. Djurković-Djaković, “Serological and molecular screening of umbilical cord blood forToxoplasma gondiiinfection; a reply to Botein et al.,” Transplant Infectious Disease, vol. 21, no. 4, article e13127, 2019.
View at: Publisher Site | Google Scholar
R. Dhakal, K. Gajurel, C. Pomares, J. Talucod, C. J. Press, and J. G. Montoya, “Significance of a positive toxoplasma immunoglobulin M test result in the United States,” Journal of Clinical Microbiology, vol. 53, no. 11, pp. 3601–3605, 2015.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Joy Nkain Ayeah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

995

Downloads

675

Citations